nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Transaminases increased—Amprenavir—acquired immunodeficiency syndrome	0.018	0.026	CcSEcCtD
Fenoldopam—DRD1—nerve—acquired immunodeficiency syndrome	0.0155	0.119	CbGeAlD
Fenoldopam—Transaminases increased—Nevirapine—acquired immunodeficiency syndrome	0.0147	0.0213	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Zidovudine—acquired immunodeficiency syndrome	0.0147	0.0213	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Zidovudine—acquired immunodeficiency syndrome	0.0129	0.0188	CcSEcCtD
Fenoldopam—Transaminases increased—Saquinavir—acquired immunodeficiency syndrome	0.00925	0.0134	CcSEcCtD
Fenoldopam—DRD2—nerve—acquired immunodeficiency syndrome	0.00917	0.0704	CbGeAlD
Fenoldopam—Creatinine increased—Abacavir—acquired immunodeficiency syndrome	0.00895	0.013	CcSEcCtD
Fenoldopam—Creatinine increased—Indinavir—acquired immunodeficiency syndrome	0.00734	0.0106	CcSEcCtD
Fenoldopam—Creatinine increased—Efavirenz—acquired immunodeficiency syndrome	0.00694	0.0101	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00603	0.00874	CcSEcCtD
Fenoldopam—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.00599	0.00869	CcSEcCtD
Fenoldopam—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00598	0.0459	CbGeAlD
Fenoldopam—Creatinine increased—Saquinavir—acquired immunodeficiency syndrome	0.00591	0.00857	CcSEcCtD
Fenoldopam—Blood creatinine increased—Abacavir—acquired immunodeficiency syndrome	0.00579	0.0084	CcSEcCtD
Fenoldopam—Blood urea increased—Ritonavir—acquired immunodeficiency syndrome	0.00552	0.008	CcSEcCtD
Fenoldopam—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00538	0.0413	CbGeAlD
Fenoldopam—Blood creatinine increased—Indinavir—acquired immunodeficiency syndrome	0.00475	0.00689	CcSEcCtD
Fenoldopam—Urinary tract infection—Stavudine—acquired immunodeficiency syndrome	0.0047	0.00682	CcSEcCtD
Fenoldopam—Cardiac failure—Delavirdine—acquired immunodeficiency syndrome	0.0047	0.00682	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Abacavir—acquired immunodeficiency syndrome	0.0047	0.00681	CcSEcCtD
Fenoldopam—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.00467	0.00677	CcSEcCtD
Fenoldopam—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00465	0.00675	CcSEcCtD
Fenoldopam—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00464	0.00672	CcSEcCtD
Fenoldopam—DRD5—nervous system—acquired immunodeficiency syndrome	0.00457	0.0351	CbGeAlD
Fenoldopam—Blood creatinine increased—Efavirenz—acquired immunodeficiency syndrome	0.00449	0.00651	CcSEcCtD
Fenoldopam—DRD5—central nervous system—acquired immunodeficiency syndrome	0.0044	0.0338	CbGeAlD
Fenoldopam—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00438	0.00635	CcSEcCtD
Fenoldopam—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.00436	0.00633	CcSEcCtD
Fenoldopam—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00436	0.00632	CcSEcCtD
Fenoldopam—Blood creatinine increased—Delavirdine—acquired immunodeficiency syndrome	0.0043	0.00623	CcSEcCtD
Fenoldopam—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00427	0.00619	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00419	0.00607	CcSEcCtD
Fenoldopam—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00403	0.00584	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00387	0.00562	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Indinavir—acquired immunodeficiency syndrome	0.00386	0.00559	CcSEcCtD
Fenoldopam—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.00383	0.00556	CcSEcCtD
Fenoldopam—Blood creatinine increased—Saquinavir—acquired immunodeficiency syndrome	0.00383	0.00555	CcSEcCtD
Fenoldopam—Urinary tract infection—Indinavir—acquired immunodeficiency syndrome	0.0038	0.00551	CcSEcCtD
Fenoldopam—DRD2—retina—acquired immunodeficiency syndrome	0.0038	0.0292	CbGeAlD
Fenoldopam—Sweating—Indinavir—acquired immunodeficiency syndrome	0.00375	0.00544	CcSEcCtD
Fenoldopam—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00374	0.0288	CbGeAlD
Fenoldopam—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00372	0.00539	CcSEcCtD
Fenoldopam—Back pain—Nelfinavir—acquired immunodeficiency syndrome	0.00367	0.00532	CcSEcCtD
Fenoldopam—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00366	0.0281	CbGeAlD
Fenoldopam—Back pain—Stavudine—acquired immunodeficiency syndrome	0.00366	0.0053	CcSEcCtD
Fenoldopam—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00365	0.00529	CcSEcCtD
Fenoldopam—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.0036	0.0277	CbGeAlD
Fenoldopam—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.00354	0.00514	CcSEcCtD
Fenoldopam—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00353	0.00512	CcSEcCtD
Fenoldopam—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00353	0.0271	CbGeAlD
Fenoldopam—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00351	0.00509	CcSEcCtD
Fenoldopam—DRD5—brain—acquired immunodeficiency syndrome	0.00349	0.0268	CbGeAlD
Fenoldopam—DRD1—nervous system—acquired immunodeficiency syndrome	0.00349	0.0268	CbGeAlD
Fenoldopam—Urinary tract infection—Delavirdine—acquired immunodeficiency syndrome	0.00344	0.00498	CcSEcCtD
Fenoldopam—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00336	0.0258	CbGeAlD
Fenoldopam—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00326	0.00472	CcSEcCtD
Fenoldopam—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00323	0.00468	CcSEcCtD
Fenoldopam—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00322	0.00468	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.00322	0.00467	CcSEcCtD
Fenoldopam—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00322	0.00466	CcSEcCtD
Fenoldopam—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00321	0.00465	CcSEcCtD
Fenoldopam—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.0032	0.00465	CcSEcCtD
Fenoldopam—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.00319	0.00463	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00319	0.00462	CcSEcCtD
Fenoldopam—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00318	0.00461	CcSEcCtD
Fenoldopam—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.00318	0.00461	CcSEcCtD
Fenoldopam—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00316	0.00458	CcSEcCtD
Fenoldopam—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00316	0.00458	CcSEcCtD
Fenoldopam—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00313	0.00454	CcSEcCtD
Fenoldopam—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00308	0.00447	CcSEcCtD
Fenoldopam—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00308	0.00446	CcSEcCtD
Fenoldopam—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00306	0.00443	CcSEcCtD
Fenoldopam—Tension—Indinavir—acquired immunodeficiency syndrome	0.003	0.00435	CcSEcCtD
Fenoldopam—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00299	0.00434	CcSEcCtD
Fenoldopam—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00298	0.00432	CcSEcCtD
Fenoldopam—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00297	0.0043	CcSEcCtD
Fenoldopam—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00296	0.00429	CcSEcCtD
Fenoldopam—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00295	0.00428	CcSEcCtD
Fenoldopam—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00294	0.00426	CcSEcCtD
Fenoldopam—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00294	0.00426	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00291	0.00421	CcSEcCtD
Fenoldopam—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00288	0.00417	CcSEcCtD
Fenoldopam—ADRA1B—brain—acquired immunodeficiency syndrome	0.00286	0.022	CbGeAlD
Fenoldopam—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00284	0.00412	CcSEcCtD
Fenoldopam—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00284	0.00412	CcSEcCtD
Fenoldopam—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00283	0.00411	CcSEcCtD
Fenoldopam—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00282	0.0041	CcSEcCtD
Fenoldopam—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00281	0.00407	CcSEcCtD
Fenoldopam—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00281	0.00407	CcSEcCtD
Fenoldopam—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.0028	0.00407	CcSEcCtD
Fenoldopam—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.0028	0.00406	CcSEcCtD
Fenoldopam—ADRA1D—brain—acquired immunodeficiency syndrome	0.0028	0.0215	CbGeAlD
Fenoldopam—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.0028	0.00406	CcSEcCtD
Fenoldopam—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.00405	CcSEcCtD
Fenoldopam—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00279	0.00405	CcSEcCtD
Fenoldopam—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00279	0.00404	CcSEcCtD
Fenoldopam—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00276	0.004	CcSEcCtD
Fenoldopam—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00275	0.0212	CbGeAlD
Fenoldopam—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00275	0.00399	CcSEcCtD
Fenoldopam—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00272	0.00395	CcSEcCtD
Fenoldopam—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00271	0.00393	CcSEcCtD
Fenoldopam—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00271	0.00393	CcSEcCtD
Fenoldopam—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.0027	0.00392	CcSEcCtD
Fenoldopam—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00268	0.00389	CcSEcCtD
Fenoldopam—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00267	0.00387	CcSEcCtD
Fenoldopam—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00267	0.00387	CcSEcCtD
Fenoldopam—DRD1—brain—acquired immunodeficiency syndrome	0.00267	0.0205	CbGeAlD
Fenoldopam—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00266	0.00385	CcSEcCtD
Fenoldopam—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00264	0.00383	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00261	0.00379	CcSEcCtD
Fenoldopam—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.0026	0.00377	CcSEcCtD
Fenoldopam—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00259	0.00376	CcSEcCtD
Fenoldopam—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00259	0.00376	CcSEcCtD
Fenoldopam—ADRA1A—blood—acquired immunodeficiency syndrome	0.00259	0.0199	CbGeAlD
Fenoldopam—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.0037	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00253	0.00367	CcSEcCtD
Fenoldopam—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.00366	CcSEcCtD
Fenoldopam—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.00366	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00252	0.00366	CcSEcCtD
Fenoldopam—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00251	0.00363	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00249	0.0036	CcSEcCtD
Fenoldopam—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.0036	CcSEcCtD
Fenoldopam—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00248	0.00359	CcSEcCtD
Fenoldopam—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00247	0.00358	CcSEcCtD
Fenoldopam—ADRA2C—blood—acquired immunodeficiency syndrome	0.00247	0.019	CbGeAlD
Fenoldopam—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00246	0.00356	CcSEcCtD
Fenoldopam—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00246	0.00356	CcSEcCtD
Fenoldopam—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00245	0.00355	CcSEcCtD
Fenoldopam—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00245	0.00355	CcSEcCtD
Fenoldopam—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00245	0.00355	CcSEcCtD
Fenoldopam—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00244	0.00354	CcSEcCtD
Fenoldopam—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00244	0.00354	CcSEcCtD
Fenoldopam—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00244	0.00354	CcSEcCtD
Fenoldopam—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00244	0.00354	CcSEcCtD
Fenoldopam—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00243	0.00353	CcSEcCtD
Fenoldopam—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00243	0.00352	CcSEcCtD
Fenoldopam—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00241	0.0035	CcSEcCtD
Fenoldopam—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.0024	0.00348	CcSEcCtD
Fenoldopam—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.0024	0.00348	CcSEcCtD
Fenoldopam—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00239	0.00347	CcSEcCtD
Fenoldopam—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.00238	0.0183	CbGeAlD
Fenoldopam—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00238	0.00345	CcSEcCtD
Fenoldopam—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00236	0.00343	CcSEcCtD
Fenoldopam—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00235	0.00341	CcSEcCtD
Fenoldopam—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00234	0.0034	CcSEcCtD
Fenoldopam—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00232	0.00336	CcSEcCtD
Fenoldopam—Tension—Lamivudine—acquired immunodeficiency syndrome	0.0023	0.00334	CcSEcCtD
Fenoldopam—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.0023	0.00333	CcSEcCtD
Fenoldopam—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00229	0.00333	CcSEcCtD
Fenoldopam—ADRA2C—vagina—acquired immunodeficiency syndrome	0.00229	0.0176	CbGeAlD
Fenoldopam—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00228	0.0033	CcSEcCtD
Fenoldopam—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00228	0.0033	CcSEcCtD
Fenoldopam—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00227	0.00329	CcSEcCtD
Fenoldopam—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00226	0.00328	CcSEcCtD
Fenoldopam—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00327	CcSEcCtD
Fenoldopam—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00226	0.00327	CcSEcCtD
Fenoldopam—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00226	0.00327	CcSEcCtD
Fenoldopam—Headache—Didanosine—acquired immunodeficiency syndrome	0.00223	0.00323	CcSEcCtD
Fenoldopam—DRD2—lung—acquired immunodeficiency syndrome	0.00223	0.0171	CbGeAlD
Fenoldopam—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00222	0.00322	CcSEcCtD
Fenoldopam—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0022	0.00319	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00219	0.00318	CcSEcCtD
Fenoldopam—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00317	CcSEcCtD
Fenoldopam—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00218	0.00316	CcSEcCtD
Fenoldopam—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00218	0.00315	CcSEcCtD
Fenoldopam—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00217	0.00314	CcSEcCtD
Fenoldopam—ADRA2C—lung—acquired immunodeficiency syndrome	0.00216	0.0166	CbGeAlD
Fenoldopam—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00213	0.00309	CcSEcCtD
Fenoldopam—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00213	0.00309	CcSEcCtD
Fenoldopam—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00212	0.00307	CcSEcCtD
Fenoldopam—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00212	0.00307	CcSEcCtD
Fenoldopam—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00307	CcSEcCtD
Fenoldopam—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00306	CcSEcCtD
Fenoldopam—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00211	0.00306	CcSEcCtD
Fenoldopam—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00211	0.00305	CcSEcCtD
Fenoldopam—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.0021	0.0162	CbGeAlD
Fenoldopam—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.0021	0.00305	CcSEcCtD
Fenoldopam—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00209	0.00304	CcSEcCtD
Fenoldopam—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00209	0.00302	CcSEcCtD
Fenoldopam—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00302	CcSEcCtD
Fenoldopam—DRD2—nervous system—acquired immunodeficiency syndrome	0.00206	0.0158	CbGeAlD
Fenoldopam—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00205	0.00297	CcSEcCtD
Fenoldopam—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00204	0.00296	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00204	0.00296	CcSEcCtD
Fenoldopam—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00204	0.00296	CcSEcCtD
Fenoldopam—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00204	0.00295	CcSEcCtD
Fenoldopam—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00203	0.00295	CcSEcCtD
Fenoldopam—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00203	0.0156	CbGeAlD
Fenoldopam—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00202	0.00292	CcSEcCtD
Fenoldopam—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00202	0.00292	CcSEcCtD
Fenoldopam—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00201	0.00291	CcSEcCtD
Fenoldopam—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00201	0.00291	CcSEcCtD
Fenoldopam—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.002	0.0154	CbGeAlD
Fenoldopam—Headache—Nevirapine—acquired immunodeficiency syndrome	0.002	0.0029	CcSEcCtD
Fenoldopam—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.002	0.0029	CcSEcCtD
Fenoldopam—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00289	CcSEcCtD
Fenoldopam—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00199	0.0152	CbGeAlD
Fenoldopam—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00197	0.00286	CcSEcCtD
Fenoldopam—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00197	0.00286	CcSEcCtD
Fenoldopam—ADRA2A—blood—acquired immunodeficiency syndrome	0.00197	0.0151	CbGeAlD
Fenoldopam—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00197	0.00285	CcSEcCtD
Fenoldopam—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00196	0.00284	CcSEcCtD
Fenoldopam—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00195	0.00282	CcSEcCtD
Fenoldopam—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00194	0.00281	CcSEcCtD
Fenoldopam—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00194	0.00281	CcSEcCtD
Fenoldopam—Headache—Stavudine—acquired immunodeficiency syndrome	0.00193	0.0028	CcSEcCtD
Fenoldopam—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00193	0.0028	CcSEcCtD
Fenoldopam—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.00193	0.0148	CbGeAlD
Fenoldopam—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.0028	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00193	0.00279	CcSEcCtD
Fenoldopam—Headache—Abacavir—acquired immunodeficiency syndrome	0.0019	0.00276	CcSEcCtD
Fenoldopam—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0019	0.00275	CcSEcCtD
Fenoldopam—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.0019	0.0146	CbGeAlD
Fenoldopam—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00189	0.00273	CcSEcCtD
Fenoldopam—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00188	0.00272	CcSEcCtD
Fenoldopam—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.0027	CcSEcCtD
Fenoldopam—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.0027	CcSEcCtD
Fenoldopam—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00186	0.0027	CcSEcCtD
Fenoldopam—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00185	0.00268	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00184	0.00267	CcSEcCtD
Fenoldopam—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00184	0.00267	CcSEcCtD
Fenoldopam—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00266	CcSEcCtD
Fenoldopam—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00183	0.00266	CcSEcCtD
Fenoldopam—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00183	0.014	CbGeAlD
Fenoldopam—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.00263	CcSEcCtD
Fenoldopam—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00181	0.00262	CcSEcCtD
Fenoldopam—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00179	0.00259	CcSEcCtD
Fenoldopam—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00179	0.00259	CcSEcCtD
Fenoldopam—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00259	CcSEcCtD
Fenoldopam—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00258	CcSEcCtD
Fenoldopam—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00258	CcSEcCtD
Fenoldopam—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00257	CcSEcCtD
Fenoldopam—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00251	CcSEcCtD
Fenoldopam—ADRA2A—lung—acquired immunodeficiency syndrome	0.00173	0.0133	CbGeAlD
Fenoldopam—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.00249	CcSEcCtD
Fenoldopam—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.00247	CcSEcCtD
Fenoldopam—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00247	CcSEcCtD
Fenoldopam—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00171	0.00247	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00171	0.00247	CcSEcCtD
Fenoldopam—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.00244	CcSEcCtD
Fenoldopam—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00165	0.00239	CcSEcCtD
Fenoldopam—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00239	CcSEcCtD
Fenoldopam—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00239	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00238	CcSEcCtD
Fenoldopam—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00164	0.00237	CcSEcCtD
Fenoldopam—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00234	CcSEcCtD
Fenoldopam—ADRA1A—brain—acquired immunodeficiency syndrome	0.00161	0.0124	CbGeAlD
Fenoldopam—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.0016	0.0123	CbGeAlD
Fenoldopam—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00159	0.00231	CcSEcCtD
Fenoldopam—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.0023	CcSEcCtD
Fenoldopam—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.0023	CcSEcCtD
Fenoldopam—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00159	0.0023	CcSEcCtD
Fenoldopam—DRD2—brain—acquired immunodeficiency syndrome	0.00158	0.0121	CbGeAlD
Fenoldopam—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00157	0.00227	CcSEcCtD
Fenoldopam—Headache—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00227	CcSEcCtD
Fenoldopam—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00226	CcSEcCtD
Fenoldopam—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00224	CcSEcCtD
Fenoldopam—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0118	CbGeAlD
Fenoldopam—ADRA2C—brain—acquired immunodeficiency syndrome	0.00153	0.0118	CbGeAlD
Fenoldopam—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00219	CcSEcCtD
Fenoldopam—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00219	CcSEcCtD
Fenoldopam—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00217	CcSEcCtD
Fenoldopam—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00216	CcSEcCtD
Fenoldopam—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00215	CcSEcCtD
Fenoldopam—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00148	0.0114	CbGeAlD
Fenoldopam—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00214	CcSEcCtD
Fenoldopam—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00208	CcSEcCtD
Fenoldopam—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00207	CcSEcCtD
Fenoldopam—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00205	CcSEcCtD
Fenoldopam—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00203	CcSEcCtD
Fenoldopam—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.002	CcSEcCtD
Fenoldopam—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00199	CcSEcCtD
Fenoldopam—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00194	CcSEcCtD
Fenoldopam—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00192	CcSEcCtD
Fenoldopam—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00192	CcSEcCtD
Fenoldopam—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.0019	CcSEcCtD
Fenoldopam—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00189	CcSEcCtD
Fenoldopam—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00185	CcSEcCtD
Fenoldopam—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00184	CcSEcCtD
Fenoldopam—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00182	CcSEcCtD
Fenoldopam—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.0018	CcSEcCtD
Fenoldopam—ADRA2A—brain—acquired immunodeficiency syndrome	0.00122	0.00939	CbGeAlD
Fenoldopam—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00176	CcSEcCtD
Fenoldopam—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00174	CcSEcCtD
Fenoldopam—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00173	CcSEcCtD
Fenoldopam—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00118	0.00907	CbGeAlD
Fenoldopam—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00165	CcSEcCtD
Fenoldopam—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000222	0.00124	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000221	0.00123	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00022	0.00122	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00022	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00022	0.00122	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000218	0.00121	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000215	0.00119	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000212	0.00118	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000212	0.00118	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000211	0.00117	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000211	0.00117	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000208	0.00116	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000205	0.00114	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000204	0.00113	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000203	0.00113	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000202	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000202	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000202	0.00112	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000202	0.00112	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000202	0.00112	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000199	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000199	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000198	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000198	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000198	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000197	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000196	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000195	0.00108	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000194	0.00108	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000191	0.00106	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000191	0.00106	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000189	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000189	0.00105	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000186	0.00103	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000186	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000185	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000185	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000183	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000183	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000182	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000182	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000182	0.00101	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00018	0.001	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00018	0.001	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00018	0.000998	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00018	0.000998	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000179	0.000996	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000179	0.000993	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000179	0.000992	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000178	0.00099	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000176	0.000977	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000173	0.00096	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000172	0.000956	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000172	0.000953	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000172	0.000953	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000172	0.000953	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000171	0.00095	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000169	0.00094	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000168	0.000935	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000168	0.000934	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000168	0.000934	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000168	0.000933	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000168	0.000933	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000167	0.000928	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000167	0.000926	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000165	0.000919	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000165	0.000919	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000165	0.000918	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000165	0.000918	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000165	0.000914	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000162	0.000901	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000162	0.000899	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000162	0.000899	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000161	0.000892	CbGpPWpGaD
Fenoldopam—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00016	0.000891	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00016	0.000888	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000156	0.000868	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000155	0.000862	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000154	0.000854	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000154	0.000853	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000154	0.000853	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000153	0.000851	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000153	0.000847	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000153	0.000847	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000152	0.000847	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000152	0.000842	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000151	0.000841	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000151	0.000837	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00015	0.000836	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00015	0.000835	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00015	0.000835	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000149	0.00083	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000149	0.00083	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000149	0.000825	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000147	0.000816	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000147	0.000816	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000145	0.000807	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000143	0.000795	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000141	0.000782	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00014	0.00078	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000139	0.000771	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000139	0.000771	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000139	0.00077	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000138	0.000769	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000138	0.000769	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000137	0.00076	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000137	0.000759	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000137	0.000759	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000137	0.000758	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000137	0.000758	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000137	0.000758	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000136	0.000754	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000135	0.000749	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000135	0.000748	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000133	0.000739	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000133	0.000736	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000129	0.000719	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000128	0.00071	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000128	0.00071	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000127	0.000705	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000127	0.000705	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000126	0.0007	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000126	0.000699	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000126	0.000699	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000125	0.000696	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000125	0.000694	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000125	0.000694	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000124	0.00069	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000124	0.000689	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000123	0.000685	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000123	0.000684	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000123	0.000684	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000121	0.000674	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00012	0.000669	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000119	0.000663	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000119	0.000663	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000118	0.000657	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000118	0.000654	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000118	0.000654	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000117	0.000649	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000116	0.000645	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000116	0.000645	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000116	0.000644	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000115	0.00064	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000115	0.000639	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000115	0.000638	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000114	0.000635	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000114	0.000635	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000113	0.00063	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000113	0.000628	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000113	0.000626	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000112	0.000621	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000111	0.000616	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00011	0.000612	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000106	0.00059	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000106	0.00059	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000106	0.000589	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000106	0.000587	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000105	0.000581	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000104	0.000577	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000104	0.000577	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000103	0.000572	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000102	0.000568	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000102	0.000567	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000101	0.000559	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.93e-05	0.000552	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.93e-05	0.000552	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.77e-05	0.000543	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.77e-05	0.000543	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.58e-05	0.000532	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.49e-05	0.000527	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	9.42e-05	0.000523	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.36e-05	0.00052	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.23e-05	0.000513	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.08e-05	0.000504	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.01e-05	0.0005	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.01e-05	0.0005	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.96e-05	0.000498	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.94e-05	0.000497	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.82e-05	0.00049	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.81e-05	0.000489	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.69e-05	0.000483	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.68e-05	0.000482	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.68e-05	0.000482	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.58e-05	0.000477	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.18e-05	0.000454	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.09e-05	0.000449	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.07e-05	0.000448	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.07e-05	0.000448	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.07e-05	0.000448	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8e-05	0.000444	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.97e-05	0.000442	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.89e-05	0.000438	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.85e-05	0.000436	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.56e-05	0.00042	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.44e-05	0.000413	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.44e-05	0.000413	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.33e-05	0.000407	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.32e-05	0.000407	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.29e-05	0.000405	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.22e-05	0.000401	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.13e-05	0.000396	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.11e-05	0.000395	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.08e-05	0.000393	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.86e-05	0.000381	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.81e-05	0.000378	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.75e-05	0.000375	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.7e-05	0.000372	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.66e-05	0.00037	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.65e-05	0.000369	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.6e-05	0.000367	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.55e-05	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.51e-05	0.000361	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.41e-05	0.000356	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.18e-05	0.000343	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.14e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.04e-05	0.000336	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.04e-05	0.000336	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.95e-05	0.000331	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.95e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.82e-05	0.000323	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	5.8e-05	0.000322	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.53e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.41e-05	0.0003	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.73e-05	0.000263	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	4.71e-05	0.000262	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.7e-05	0.000261	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.66e-05	0.000259	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.64e-05	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.21e-05	0.000234	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.19e-05	0.000233	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.18e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.93e-05	0.000218	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.91e-05	0.000217	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.87e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.85e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.57e-05	0.000198	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.55e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.44e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.42e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.19e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.18e-05	0.000177	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.74e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.47e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.31e-05	0.000128	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.28e-05	0.000126	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.1e-05	0.000116	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.88e-05	0.000104	CbGpPWpGaD
